ARC1905 (Anti-C5 Aptamer) Given With Lucentis 0.5 mg In People With Neovascular Age-Related Macular Degeneration
Clinical trial NCT00709527 · COMPLETED
Trial details
- NCT number
- NCT00709527
- Sponsor
- Ophthotech Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-16
- Primary completion
- 2009-12-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.